Porto, Italo
 Distribuzione geografica
Continente #
EU - Europa 6.416
NA - Nord America 5.794
AS - Asia 1.096
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 16
SA - Sud America 16
Totale 13.385
Nazione #
US - Stati Uniti d'America 5.780
DE - Germania 3.096
SE - Svezia 1.003
CN - Cina 787
UA - Ucraina 549
IT - Italia 502
FR - Francia 319
IE - Irlanda 305
GB - Regno Unito 274
FI - Finlandia 126
IN - India 102
TR - Turchia 81
PL - Polonia 71
BE - Belgio 37
JP - Giappone 37
AT - Austria 31
NL - Olanda 25
RU - Federazione Russa 20
IR - Iran 19
EU - Europa 18
HK - Hong Kong 18
AU - Australia 13
SG - Singapore 12
CA - Canada 11
ES - Italia 10
ET - Etiopia 10
CZ - Repubblica Ceca 9
BR - Brasile 7
EG - Egitto 7
AR - Argentina 6
CH - Svizzera 6
VN - Vietnam 6
BG - Bulgaria 5
KR - Corea 5
MA - Marocco 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GR - Grecia 4
HR - Croazia 4
ID - Indonesia 4
MD - Moldavia 4
MY - Malesia 4
NO - Norvegia 4
TW - Taiwan 4
BD - Bangladesh 3
CI - Costa d'Avorio 3
IL - Israele 3
NZ - Nuova Zelanda 3
QA - Qatar 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DK - Danimarca 2
HU - Ungheria 2
LU - Lussemburgo 2
AL - Albania 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CL - Cile 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 13.385
Città #
Chandler 1.513
Ashburn 374
San Mateo 338
Jacksonville 327
Dublin 302
New York 259
Nanjing 217
Nürnberg 216
Wilmington 177
Ann Arbor 165
Boston 126
Marseille 122
Dearborn 121
Cattolica 110
Milan 107
Nanchang 104
Woodbridge 100
Lawrence 93
Munich 92
Princeton 79
Beijing 78
Houston 78
Izmir 71
Lancaster 69
Redwood City 65
Seattle 61
Bremen 52
Fairfield 50
Hebei 49
Mountain View 44
Detroit 42
Leawood 40
Kunming 38
Shenyang 37
Brussels 36
Kraków 36
Changsha 31
University Park 31
Vienna 31
Warsaw 31
Zhengzhou 31
Rome 29
Norwalk 27
Shanghai 27
Los Angeles 26
Redmond 26
Tianjin 26
Boardman 25
Jiaxing 25
Andover 23
Augusta 20
Helsinki 19
Hangzhou 18
Pune 18
Chicago 17
London 17
Washington 16
Cambridge 15
Fremont 15
San Francisco 15
Simi Valley 15
Hong Kong 13
Changchun 12
Orange 12
Saint Louis 12
Bari 11
Guangzhou 11
Lanzhou 11
Indiana 10
Philadelphia 10
Phoenix 10
Tokyo 10
Busto Arsizio 9
Groningen 8
Hefei 8
Genova 7
Kish 7
Renton 7
Almere Stad 6
Amsterdam 6
Berlin 6
Edinburgh 6
Genoa 6
Toronto 6
Bologna 5
Frankfurt am Main 5
Jinan 5
Moscow 5
Salé 5
Singapore 5
Yellow Springs 5
Ardabil 4
Buffalo 4
Catania 4
Chisinau 4
Chongqing 4
Costa Mesa 4
Hanoi 4
Istanbul 4
League City 4
Totale 6.637
Nome #
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 209
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 196
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 194
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 189
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 180
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 177
Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina 174
Renal artery stenting in patients with chronic ischemic heart disease 172
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 165
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 162
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 156
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 152
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 144
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 143
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling 140
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 137
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 137
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 135
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 133
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 132
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 132
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 128
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 128
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 125
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 125
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 124
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease 124
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 122
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 122
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 120
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 117
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 117
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 116
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 116
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 115
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 115
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 115
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 109
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 106
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 105
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 104
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 103
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 103
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 102
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 101
Ethanol abolishes ischemic preconditioning in humans 100
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 100
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 100
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 100
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 99
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 98
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 97
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 96
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 96
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 96
A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome 95
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 93
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 93
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 93
A current approach to heart failure in Duchenne muscular dystrophy 92
Coronary Stenosis as an Innocent Bystander in Acute Coronary Syndrome 90
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 89
Left anterior descending artery percutaneous coronary intervention from the right radial access via the left internal mammary artery: A case report 88
Long-term morphofunctional remodeling of internal thoracic artery grafts: a frequency-domain optical coherence tomography study 88
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 88
Angiographic assessment of microvascular perfusion--myocardial blush in clinical practice 83
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 81
Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography 80
Dual role of circulating endothelial progenitor cells in stent struts endothelialisation and neointimal regrowth: a substudy of the IN-PACT CORO trial 80
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion 80
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) 79
Trends and Outcomes of Radial Approach in Left-Main Bifurcation Percutaneous Coronary Intervention in the Drug-Eluting Stent Era: A Two-Center Registry 79
Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance 78
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 78
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 78
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 77
One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology 76
Microparticles in health and disease: small mediators, large role? 75
Predictors of myocardial microvascular obstruction in patients treated by primary percutaneous coronary intervention and a short ischemic time 74
A case of variant angina in a patient under chronic treatment with sorafenib 74
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 74
Morphological-biohumoral correlations in acute coronary syndromes: Pathogenetic implications 73
DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging 73
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 72
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 71
Post-procedural renal microvascular perfusion measured using the Quantitative Blush Evaluator (QuBE) predicts improvement in renal function in patients undergoing percutaneous renal artery stenting 70
Three-year follow-up of patients with bifurcation lesions treated with sirolimus- or everolimus-eluting stents: SEAside and CORpal cooperative study 69
Radial artery intima-media ratio predicts presence of coronary thin-cap fibroatheroma: a frequency domain-optical coherence tomography study 68
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 68
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study 65
Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions 64
temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation 63
Mechanisms, prevention and treatment of distal embolization 62
Clinical impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome 62
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography 62
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 61
The Multi-center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO in Predicting FFR (MEMENTOFFR) Study 60
Coronary Stenosis as an Innocent Bystander in Acute Coronary Syndrome 59
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 59
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 59
Totale 10.498
Categoria #
all - tutte 45.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019375 0 0 0 0 0 0 0 0 0 113 161 101
2019/20201.778 340 93 143 86 144 143 192 53 157 114 172 141
2020/20211.198 39 117 24 127 147 97 151 41 174 51 185 45
2021/20221.701 118 115 28 84 109 49 48 304 66 115 302 363
2022/20233.673 432 576 337 571 168 489 164 284 462 63 94 33
2023/20241.337 71 487 54 84 76 348 90 65 28 34 0 0
Totale 13.667